A number of studies have demonstrated that RAD51AP1 is overexpressed and serves as an carcinogenic role in several tumors, including ovarian cancer [7], lung cancer [8], breast cancer [9], as well as hepatocellular carcinoma [10]. This evidence concerns the gene RAD51AP1 and ovarian carcinoma.